Literature DB >> 31220375

Pentosidine Is Associated With Cortical Bone Geometry and Insulin Resistance in Otherwise Healthy Children.

Joseph M Kindler1, Emma M Laing1, Weixi Liu2, Joel A Dain2, Richard D Lewis1.   

Abstract

Pentosidine is an advanced glycation end product (AGE) associated with fracture in adults with diabetes. AGE accumulation in bone collagen contributes to bone fragility but might also adversely influence bone turnover and, consequently, bone geometry. The relationships between AGEs and bone health have yet to be studied in children. Thus, the objective of this study was to assess relationships between pentosidine and cortical bone volumetric density, geometry, and estimated strength in children. Participants were otherwise healthy black and white boys and girls, ages 9 to 13 years, who were at sexual maturation stage 2 or 3 (N = 160). Tibia and radius cortical bone and muscle area (66% site) were assessed via pQCT. In fasting sera, insulin, glucose, and pentosidine were measured. The Quantitative Insulin Sensitivity Check Index (QUICKI), a measure of insulin sensitivity, was calculated. While controlling for race, sex, maturation, and height, pentosidine negatively correlated with QUICKI (P < 0.05). In unadjusted analyses, pentosidine was associated with lower radius and tibia cortical volumetric bone mineral density, bone mineral content (Ct.BMC), area (Ct.Ar), and thickness (Ct.Th); a larger radius endosteal circumference (Endo.Circ); and lower tibia polar strength strain index (all P < 0.05). While controlling for race, sex, maturation, height, and muscle area, pentosidine was negatively associated with tibia Ct.BMC, Ct.Ar, and Ct.Th but positively associated with Endo.Circ (all P < 0.05). Linear regression revealed a significant interaction between pentosidine and QUICKI in relation to tibia Ct.Th (pinteraction = 0.049), indicating that the negative relationship between pentosidine and Ct.Th was stronger in those with lower QUICKI (ie, greater insulin resistance). This is the first study to report evidence of a potentially adverse influence of AGEs on bone strength in otherwise healthy children. This relationship was strongest in children with the greatest insulin resistance, supporting further work in youth with chronic metabolic health conditions.
© 2019 American Society for Bone and Mineral Research. © 2019 American Society for Bone and Mineral Research.

Entities:  

Keywords:  ADVANCED GLYCATION END PRODUCT; BONE GEOMETRY IN CHILDREN; INSULIN RESISTANCE; PENTOSIDINE

Year:  2019        PMID: 31220375      PMCID: PMC6697211          DOI: 10.1002/jbmr.3727

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  24 in total

1.  Longitudinal study on pubertal insulin resistance.

Authors:  M I Goran; B A Gower
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

2.  Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes.

Authors:  Ann V Schwartz; Eric Vittinghoff; Douglas C Bauer; Teresa A Hillier; Elsa S Strotmeyer; Kristine E Ensrud; Meghan G Donaldson; Jane A Cauley; Tamara B Harris; Annemarie Koster; Catherine R Womack; Lisa Palermo; Dennis M Black
Journal:  JAMA       Date:  2011-06-01       Impact factor: 56.272

3.  Lower bone mass in prepubertal overweight children with prediabetes.

Authors:  Norman K Pollock; Paul J Bernard; Karl Wenger; Sudipta Misra; Barbara A Gower; Jerry D Allison; Haidong Zhu; Catherine L Davis
Journal:  J Bone Miner Res       Date:  2010-07-16       Impact factor: 6.741

4.  Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

Authors:  A Katz; S S Nambi; K Mather; A D Baron; D A Follmann; G Sullivan; M J Quon
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

5.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

6.  High serum concentrations of pentosidine, an advanced glycation end product, are associated with low normal value of ankle-brachial index in apparently healthy men.

Authors:  Ryotaro Takahashi; Akiko Imamura; Mari Yoshikane; Masayuki Suzuki; Ryuichiro Murakami; Xian Wu Cheng; Yasushi Numaguchi; Nobuo Ikeda; Toyoaki Murohara; Kenji Okumura
Journal:  Metabolism       Date:  2010-08-17       Impact factor: 8.694

7.  Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.

Authors:  Mohsen Kerkeni; Amel Saïdi; Hassan Bouzidi; Ahmed Letaief; Salim Ben Yahia; Mohamed Hammami
Journal:  Diab Vasc Dis Res       Date:  2012-10-22       Impact factor: 3.291

8.  Pentosidine and increased fracture risk in older adults with type 2 diabetes.

Authors:  Ann V Schwartz; Patrick Garnero; Teresa A Hillier; Deborah E Sellmeyer; Elsa S Strotmeyer; Kenneth R Feingold; Helaine E Resnick; Frances A Tylavsky; Dennis M Black; Steven R Cummings; Tamara B Harris; Douglas C Bauer
Journal:  J Clin Endocrinol Metab       Date:  2009-04-21       Impact factor: 5.958

9.  Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease.

Authors:  Irena Makulska; Maria Szczepańska; Dorota Drożdż; Dorota Polak-Jonkisz; Danuta Zwolińska
Journal:  Pediatr Nephrol       Date:  2012-09-15       Impact factor: 3.714

10.  Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men.

Authors:  H Momma; K Niu; Y Kobayashi; L Guan; M Sato; H Guo; M Chujo; A Otomo; C Yufei; H Tadaura; T Saito; T Mori; T Miyata; R Nagatomi
Journal:  Osteoporos Int       Date:  2011-09-08       Impact factor: 4.507

View more
  2 in total

1.  Effects of cheerleading practice on advanced glycation end products, areal bone mineral density, and physical fitness in female adolescents.

Authors:  Lijun Wang; Hongli Zhang; Tuo Xu; Jing Zhang; Yuanyuan Liu; Yue Qu
Journal:  Front Physiol       Date:  2022-09-05       Impact factor: 4.755

Review 2.  Glycemic Control and Bone in Diabetes.

Authors:  David R Weber; Fanxin Long; Babette S Zemel; Joseph M Kindler
Journal:  Curr Osteoporos Rep       Date:  2022-10-10       Impact factor: 5.163

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.